Micha Breakstone
Co-founder & CEO
Your CSV is on the way
We’ve sent your CSV file to email@email.com
Claimed by
owner Add to list
Somite.ai
Former names:
AI-based Platform to Produce Human Tissue for Cell-based Therapies
Stealth Mode
Somite.ai
Somite.ai Overview
Somite.ai is aiming to become the OpenAI of stem cell biology, developing AI foundation models to produce human tissue for cell therapies at scale for diseases such as diabetes, obesity, and muscular dystrophies. Somite's AI platform, AlphaStem, fuels a virtuous cycle as it enables new cell therapies, generating massive data that further improve the platform, empowering even faster therapy creation with broader applications. The company's pipeline includes the promising SMT-M01 program for Duchenne muscular dystrophy (DMD) and the SMT-B01 program for metabolic disorders.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Somite.ai Climate Tech relevance
null
No Data, yet.
Sorry, no content found under this section.
Jun 9, 2025
www.themarker.com
חברת Somite.ai בהובלת מדענים ישראלים מנסה לפתור בעיה שמעסיקה חוקרים כבר עשורים: איך לגרום לתא גזע להפוך בדיוק למה שצריך — ובקנה מידה תעשייתי. אם תצליח, תאים ביולוגיים יוכלו להחליף תרופות — ולשקם תפקודים שאבדו
undefined
May 13, 2025
www.calcalistech.com
Somite AI secures $47.5 million Series A to expand AI platform for cell therapy | CTech
#Investment #Management Changes
May 13, 2025
en.globes.co.il
Somite AI is building DeltaStem, a platform and foundation model designed to revolutionize the production of human cells.
#Investment
Sep 10, 2024
www.calcalistech.com
Before joining Somite.ai, Kivity served as Chief of Staff and first U.S. employee at 4M Analytics. He joins the company after completing over 250 days of reserve duty in the Iron Swords war as a Deputy Battalion Commander in Gaza.
#Management Changes #Investment
Sep 3, 2024
www.calcalistech.com
Somite.ai takes pre-seed to $10M as it eyes to become ‘the OpenAI of stem cell biology’ | CTech
#Investment
Companies you might be interested in
Driven by Finder AI
-
CellCure NeurosciencesCell Therapies for Neural Degenerative Diseases11-50 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
DenovAI BiotechDynamic Protein Design11-50 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
TenAces BiosciencesMolecular Glue Therapeutics1-10 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
ViroScanner AIAccelerating Viral Cures through Intelligent Molecular SynthesisAre these companies similar?
Primary sector
Total funding
Funding stage
Number of employees
Founded
Related Content
Lists. Maps. Reports
Team Members
MB
OP
JS
AK
CT
JR
Contact Team
Affiliated Organizations
(null)Web & social links
https://www.cellularintelligence.com
Locations
Israel
Israel
Offices Abroad
240 Longwood Ave, Boston, MA 02115, USA
Photos & videos
(0)No Data, yet.
Sorry, no content found under this section.
Somite.ai Business
Sector
Primary:
Health Tech & Life Sciences
Target Customer
Core Technology
Use Cases
(0)Tech Community Involvement
(0)Somite.ai Financials
Cumulative Funding Raised Over Time ($)
No Data, yet.
Sorry, no content found under this section.
Public Offerings & Exits
Private Equity Funding
A Round
$47.5M
May 2025
9
Investors
$47.5M
Lead
Khosla Ventures
VC and Private Equity
United States
Fusion Fund
VC and Private Equity
United States
Ajinomoto
Multinational
Japan
Martin Chavez
Angel
United States
TechAviv
Founders
Israel
Pitango HealthTech
VC and Private Equity
Israel
Scifi VC
VC and Private Equity
United States
Chan Zuckerberg Initiative
VC and Private Equity
United States
Harpoon Ventures
VC and Private Equity
United States
Seed
$4.7M
Sep 2024
2
Investors
$4.7M
Pre-Seed
$5.3M
Apr 2024
5
Investors
$5.3M
Non-Equity Funding
Mergers and Acquisitions
Somite.ai Lifecycle
Cumulative Funding Raised Over Time ($)
Timeline
Employees Over Time
News Over Time
No Data, yet.
Sorry, no content found under this section.
A Round
$47.5M
May 2025
9
Investors
$47.5M
Lead
Khosla Ventures
VC and Private Equity
United States
Fusion Fund
VC and Private Equity
United States
Ajinomoto
Multinational
Japan
Martin Chavez
Angel
United States
TechAviv
Founders
Israel
Pitango HealthTech
VC and Private Equity
Israel
Scifi VC
VC and Private Equity
United States
Chan Zuckerberg Initiative
VC and Private Equity
United States
Harpoon Ventures
VC and Private Equity
United States
Seed
$4.7M
Sep 2024
2
Investors
$4.7M
Pre-Seed
$5.3M
Apr 2024
5
Investors
$5.3M
Somite.ai News
News Over Time
No Data, yet.
Sorry, no content found under this section.
News Articles
Jun 9, 2025
www.themarker.com
חברת Somite.ai בהובלת מדענים ישראלים מנסה לפתור בעיה שמעסיקה חוקרים כבר עשורים: איך לגרום לתא גזע להפוך בדיוק למה שצריך — ובקנה מידה תעשייתי. אם תצליח, תאים ביולוגיים יוכלו להחליף תרופות — ולשקם תפקודים שאבדו
undefined
May 13, 2025
www.calcalistech.com
Somite AI secures $47.5 million Series A to expand AI platform for cell therapy | CTech
#Investment #Management Changes
May 13, 2025
en.globes.co.il
Somite AI is building DeltaStem, a platform and foundation model designed to revolutionize the production of human cells.
#Investment
Sep 10, 2024
www.calcalistech.com
Before joining Somite.ai, Kivity served as Chief of Staff and first U.S. employee at 4M Analytics. He joins the company after completing over 250 days of reserve duty in the Iron Swords war as a Deputy Battalion Commander in Gaza.
#Management Changes #Investment
Sep 3, 2024
www.calcalistech.com
Somite.ai takes pre-seed to $10M as it eyes to become ‘the OpenAI of stem cell biology’ | CTech
#Investment
Somite.ai Team
No Data, yet.
Sorry, no content found under this section.
MB
OP
Olivier Pourquie
Co-founder
JS
Jay Shendure
Co-founder
AK
Allon Klein
Co-founder
CT
Cliff Tabin
Co-founder
JR
Jonathan Rosenfeld
Co-founder & CTO
JS
Jay Shendure,
Scientific Co-founder
KJ
Kristy J.
Chief DEV. officer
NM
Nuno Mendonça
Chief medical officer
SK
Shai Kivity
VP of Strategy & Ops
AR
Arjun Raj
Head of Computational Biology
Employees Over Time
Companies you might be interested in
Driven by Finder AI
-
CellCure NeurosciencesCell Therapies for Neural Degenerative Diseases11-50 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
DenovAI BiotechDynamic Protein Design11-50 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
TenAces BiosciencesMolecular Glue Therapeutics1-10 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
ViroScanner AIAccelerating Viral Cures through Intelligent Molecular SynthesisAre these companies similar?
Somite.ai Internal
Create note
Notes
(undefined)
Filter notes
Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Access Comprehensive Financial Analytics
Create a free account to:
- Explore detailed financial analytics.
- Track company growth and size.
- Connect with company team members.
I already have access,
I already have access,